1d
Clinical Trials Arena on MSNBlue Earth’s radioligand therapy achieves high tumour radiation absorptionResults from the company’s Phase I/II trial showed the injectable therapy to have an effective half-life of 91.4 hours.
Researchers said alpha particles are promising therapies that target cancer while minimizing the damage to nearby healthy tissues.
Oncology nurses play essential roles in the emerging field of cardio-oncology, which aims to protect patients’ heart function ...
Scientists at UCLA have discovered a potential new way to treat glioblastoma, the most aggressive type of brain cancer. Their ...
Even modern cancer treatments appear risky for the heart, especially if the radiation dose to the LAD is high.
Senators Thom Tillis (R-NC) and Gary Peters (D-MI) introduced the Radiation Oncology Case Rate (ROCR) Value-Based Program Act ...
Men who experience acute adverse effects after radiation therapy for prostate cancer may be at higher risk for more serious ...
A dermatology expert panel confirms image-guided superficial radiation therapy as a safe, effective first-line treatment for ...
Lu rhPSMA-10.1 showed high tumor radiation with low healthy tissue exposure in a phase 1/2 trial for metastatic ...
Black women tend to get more aggressive uterine cancers than White women. But this is only part of the story, investigators ...
Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive drug that emits alpha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results